These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6675422)

  • 21. Dimethylacetamide (DMAC) and dimethylformamide (DMFA). Effect on percutaneous absorption.
    Munro DD; Stoughton RB
    Arch Dermatol; 1965 Nov; 92(5):585-6. PubMed ID: 5844405
    [No Abstract]   [Full Text] [Related]  

  • 22. Percutaneous absorption kinetics of topical metronidazole formulations in vitro in the human cadaver skin model.
    Elewski BE
    Adv Ther; 2007; 24(2):239-46. PubMed ID: 17565913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The transdermal drug delivery system and transcutaneous absorption.
    Morimoto Y; Sugibayashi K; Natsume H
    Acta Derm Venereol Suppl (Stockh); 1994; 185():15-7. PubMed ID: 8091920
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel foam vehicle for delivery of topical corticosteroids.
    Huang X; Tanojo H; Lenn J; Deng CH; Krochmal L
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S26-38. PubMed ID: 15968261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Percutaneous absorption: topical and systemic treatments].
    Machet L; Baïcan A; Pelucio-Lopes C; Patat F; Vaillant L
    Ann Dermatol Venereol; 1997; 124(6-7):490-6. PubMed ID: 9739917
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of formulation factors on the availability of drugs from topical preparations.
    Asche H; Botta L; Rettig H; Weirich EG
    Pharm Acta Helv; 1985; 60(8):232-7. PubMed ID: 4070318
    [No Abstract]   [Full Text] [Related]  

  • 27. Middle ear application of a sodium hyaluronate gel loaded with neomycin in a Guinea pig model.
    Saber A; Laurell G; Bramer T; Edsman K; Engmér C; Ulfendahl M
    Ear Hear; 2009 Feb; 30(1):81-9. PubMed ID: 19125030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cosmeceutical vehicles.
    Epstein H
    Clin Dermatol; 2009; 27(5):453-60. PubMed ID: 19695476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vehicles based on a sugar surfactant: Colloidal structure and its impact on in vitro/in vivo hydrocortisone permeation.
    Savić SD; Savić MM; Vesić SA; Vuleta GM; Müller-Goymann CC
    Int J Pharm; 2006 Aug; 320(1-2):86-95. PubMed ID: 16730932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vehicle effects on in vitro skin permeation of thiocolchicoside.
    Bonina F; Puglia C; Trombetta D; Dragani MC; Gentile MM; Clavenna G
    Pharmazie; 2002 Nov; 57(11):750-2. PubMed ID: 12611278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal delivery of phosphorodiamidate Morpholino oligomers across hairless mouse skin.
    Pannier AK; Arora V; Iversen PL; Brand RM
    Int J Pharm; 2004 May; 275(1-2):217-26. PubMed ID: 15081152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of penetration enhancers for testosterone transdermal delivery from spray formulations.
    Leichtnam ML; Rolland H; Wüthrich P; Guy RH
    J Control Release; 2006 Jun; 113(1):57-62. PubMed ID: 16677734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles.
    Feldman SR; Sangha N; Setaluri V
    J Am Acad Dermatol; 2000 Jun; 42(6):1017-20. PubMed ID: 10827406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of celecoxib through human skin.
    Yener G; Gönüllü U; Uner M; Değim T; Araman A
    Pharmazie; 2003 May; 58(5):330-3. PubMed ID: 12779049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of vehicle on assessment of relative skin sensitization potency of 1,4-dihydroquinone in the local lymph node assay.
    Lea LJ; Warbrick EV; Dearman RJ; Kimber I; Basketter DA
    Am J Contact Dermat; 1999 Dec; 10(4):213-8. PubMed ID: 10594297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative formulation for patients with contact reactions to topical 2% and 5% minoxidil vehicle ingredients.
    Scheman AJ; West DP; Hordinksy MK; Osburn AH; West LE
    Contact Dermatitis; 2000 Apr; 42(4):241. PubMed ID: 10750861
    [No Abstract]   [Full Text] [Related]  

  • 37. [Quantitative aspects of the extrapolation of experimental data from animals to man in chemical substance uptake through the skin].
    Gostinskiĭ VD; Krasnopevtseva GB
    Gig Tr Prof Zabol; 1979 Aug; (8):30-2. PubMed ID: 488721
    [No Abstract]   [Full Text] [Related]  

  • 38. Topical delivery of retinyl ascorbate. 3. Influence of follicle sealing and skin stretching.
    Abdulmajed K; Heard CM
    Skin Pharmacol Physiol; 2008; 21(1):46-9. PubMed ID: 18025843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designing for topical delivery: prodrugs can make the difference.
    Sloan KB; Wasdo S
    Med Res Rev; 2003 Nov; 23(6):763-93. PubMed ID: 12939791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ability of certain additives to influence the absorption of salicylic acid from solutions in an in vivo study: preliminary report.
    Whitworth CW; Yantis LD
    J Pharm Sci; 1967 Dec; 56(12):1661-3. PubMed ID: 5588724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.